Aridis Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development of novel, differentiated therapies for infectious diseases. Complementing the product pipeline is a disruptive platform technology to discover rare, potent human monoclonal antibodies from patients. Their scientists and leadership team have a proven track record of innovation and successful drug development of therapeutic candidates from early discovery to commercial implementation.

Biotechnology

Aridis Pharmaceutical

Vu L. Truong

Fred Kurland

Hasan Jafri

Steven Chamow

Elizabeth Leininger

Jeffrey J. Fessler

The executive team at Aridis Pharmaceuticals has a long history of experience in the field of infectious diseases and vaccines. The team has worked on product development, clinical research, and pediatric pharmacology. They have also been involved in coordinating large-scale clinical trials. In terms of education, the team has degrees in pediatrics and pediatric infectious diseases.

CEO and Executive Team

Leadership Team

Board of Directors

CEO and Executive Team

About

Team members

Other teams at Aridis Pharmaceutical

Leadership Team

Board of Directors